The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases

Journal of Nuclear Medicine Technology

Volumn 27, Issue 4, 1999, Pages 279-281

  Yaakob, William ^a   Gordon, Leonie ^a   Spicer, Kenneth M ^a   Nitke, Steven J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Metastases; Sodium iodine 123; Sodium iodine 131; Thyroid carcinoma; Whole body imaging

Indexed keywords

IODINE 123;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG EFFICACY; HUMAN; IMAGE ANALYSIS; METASTASIS; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING;

BONE NEOPLASMS; CARCINOMA; HEAD AND NECK NEOPLASMS; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; THYROID NEOPLASMS;

EID: 0033392597     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Berkow R, ed. The Merck Manual of Diagnosis and Therapy. 15th ed. Rahway, NJ:Merck, Sharp & Dohme Research Laboratories;1987:1048.
2. Mettler FA, Guiberteau MJ, Essentials of Nuclear Medicine Imaging. 3rd ed. Philadelphia, PA: W.B. Sannders Co.; 1991:87-93.
3. Reynolds JC, Robbies J. The changing role of radioiodine in the management of differenciated thyroid cancer. Semin Nucl Med. 1997;27:152-164.
4. Rawson RW, Rall JE, Peacock W. Limitations and indications in the treatment of cancer of the thyroid with radioactive iodine. J Clin Endocrinol 1951;11:1128-1142.
5. Park HM, ParK YH, Zhou XH. Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma. Thyroid. 1997:7:277-280.